Egyszerű nézet

dc.contributor.author Bogáthy, Emese
dc.contributor.author Papp, Noémi
dc.contributor.author Vas, Szilvia
dc.contributor.author Bagdy, György
dc.contributor.author Tóthfalusi, László
dc.date.accessioned 2019-08-25T19:44:57Z
dc.date.available 2019-08-25T19:44:57Z
dc.date.issued 2019
dc.identifier.citation journalVolume=10; pagination=Paper 831, 10 pages; journalTitle=FRONTIERS IN PHARMACOLOGY;journalAbbreviatedTitle=FRONT PHARMAC;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/7500
dc.identifier.uri doi:10.3389/fphar.2019.00831
dc.description.abstract Study objectives: a) To describe the microarchitecture of wakefulness and sleep following administrations of 5 and 10 mg/kg AM-251 in rats. b) To develop a new statistical method to follow bout-to-bout dynamics. Method: Wistar rats (n = 6) had been equipped with electroencephalography (EEG) and electromyography (EMG) electrodes. Following their recovery and habituation after the surgery, the animals were injected with vehicle and 5 and 10 mg/kg AM-251 intraperitoneally and EEG, EMG and motor activity was analyzed for the subsequent three hours. Results: AM-251 induced a dose- and time-dependent increase in the number of bouts in active wake (AW) and it decreased this number in all other vigilance states except in passive wake (PW). In contrast, the bout duration in PW compensatory decreased. The effect of AM-251 on the sleep transition dynamics was monitored with a new tool we call "transition heatmap". The analysis of bout trajectories with transition heatmaps reveals a highly organized pattern. Conclusion: AM-251 selectively influences the frequency of vigilance state transitions, but it has no direct impact on the state lengths. AM-251 markedly changed the state transition dynamics, which was visualized with the help of state transition heatmaps.
dc.relation.ispartof urn:issn:1663-9812
dc.title AM-251, A Cannabinoid Antagonist, Modifies the Dynamics of Sleep–Wake Cycles in Rats
dc.type Journal Article
dc.date.updated 2019-08-19T18:13:03Z
dc.language.rfc3066 en
dc.rights.holder NULL
dc.identifier.mtmt 30750621
dc.contributor.institution MTA-SE-NAP B Genetikai Agyi Képalkotó Migrén Kutató Csoport
dc.contributor.institution NAP-A-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport
dc.contributor.institution NAP-2-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport
dc.contributor.institution MTA-SE Neuropszichofarmakológiai Kutatócsoport (2007-től társult tag)
dc.contributor.institution Gyógyszerhatástani Intézet
dc.contributor.institution MTA-SE Neuropszichofarmakológiai és Neurokémiai Kutatócsoport
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet